Triclosan safety study
This article was originally published in The Tan Sheet
Executive Summary
"13-Week dermal subchronic toxicity study of triclosan in rats" anticipated to begin by year-end, according to the Triclosan Industry Alliance. The study is being conducted to support Category I status of the antimicrobial ingredient in the monograph for antimicrobial wash products, issued in June 1994. Under the protocol, rats will receive once daily applications for 91 days of .3 mg, 1 mg, 3 mg or 5 mg triclosan, and skin will be assessed for various endpoints. Members of the alliance include Colgate-Palmolive (Softsoap), Dial (Dial), Procter & Gamble (Safeguard), SmithKline Beecham (Oxy), Unilever (Lever 2000), Block Drug (Lava) and Ciba Specialty Chemicals. The protocol was submitted by Colgate. NDAC is meeting July 29 for discussion of product testing requirements for the antimicrobial product monograph, but is not expected to consider the triclosan protocol...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning